VEGFA and metabolic dysfunction-associated steatotic liver disease: Furthermore, in NAFLD patients, a correlation has been observed between vWF and the expression of collagen XV, which is a specific marker of portal myofibroblasts with pro-angiogenic properties by secreting extracellular vesicles containing VEGF [28].